📰 Repligen Co News
Page 7 - Repligen Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Repligen Co. Real-time updates on events, politics, business and more.
May 16, 2023
Raymond James & Associates lowered its holdings in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,911 shares of the biotechnology company’s stock after selling 529 shares during the quarter. Raymond […]
May 13, 2023
California Public Employees Retirement System trimmed its holdings in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 7.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 104,450 shares of the biotechnology company’s stock after selling 8,870 shares during the period. California Public Employees […]
May 13, 2023
Skandinaviska Enskilda Banken AB publ bought a new position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 9,679 shares of the biotechnology company’s stock, valued at approximately $1,639,000. Several other hedge funds have also modified […]
May 9, 2023
Repligen Co. (NASDAQ:RGEN – Get Rating) Director Martin D. Madaus acquired 500 shares of the business’s stock in a transaction dated Monday, May 8th. The stock was acquired at an average cost of $156.18 per share, with a total value of $78,090.00. Following the purchase, the director now directly owns 1,611 shares in the company, […]
May 7, 2023
Repligen Co. (NASDAQ:RGEN – Get Rating) – Research analysts at SVB Leerink lowered their Q4 2023 earnings per share estimates for Repligen in a note issued to investors on Tuesday, May 2nd. SVB Leerink analyst P. Souda now forecasts that the biotechnology company will post earnings per share of $0.63 for the quarter, down from […]
May 7, 2023
Gulf International Bank UK Ltd bought a new stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 10,515 shares of the biotechnology company’s stock, valued at approximately $1,780,000. A number of other hedge funds and other institutional […]
May 6, 2023
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 16,431 shares of the biotechnology company’s stock, valued at approximately $2,662,000. Other large investors also recently added […]
May 4, 2023
Repligen Co. (NASDAQ:RGEN – Get Rating) – Stock analysts at William Blair reduced their Q3 2023 earnings estimates for Repligen in a research report issued on Wednesday, May 3rd. William Blair analyst M. Larew now forecasts that the biotechnology company will post earnings of $0.52 per share for the quarter, down from their prior forecast […]
May 2, 2023
Geneva Capital Management LLC reduced its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 8.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 129,065 shares of the biotechnology company’s stock after selling 12,348 shares during the quarter. Geneva […]
April 19, 2023
Repligen Co. (NASDAQ:RGEN – Get Rating) – Stock analysts at William Blair lifted their Q1 2023 earnings per share estimates for Repligen in a research note issued to investors on Wednesday, April 12th. William Blair analyst M. Larew now expects that the biotechnology company will earn $0.72 per share for the quarter, up from their […]